Ana Belén
Nieto Librero
Profesora Titular de Universidad
![Foto de Pablo Vicente](/img/nophoto.png)
Pablo Vicente
Escribá Ruiz
Pablo Vicente Escribá Ruiz-rekin lankidetzan egindako argitalpenak (1)
2024
-
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Spinal Cord, Vol. 62, Núm. 8, pp. 454-467